Journal of Medical Virology,
Journal Year:
2022,
Volume and Issue:
94(9), P. 4071 - 4087
Published: April 30, 2022
Since
the
outbreak
of
coronavirus
disease
2019
(COVID-19)
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection,
global
public
health
and
economy
have
suffered
unprecedented
damage.
Based
on
increasing
related
literature,
characteristics
pathogenic
mechanisms
virus,
epidemiological
clinical
features
are
being
rapidly
discovered.
The
spike
glycoprotein
(S
protein),
as
a
key
antigen
SARS-CoV-2
for
developing
vaccines,
antibodies,
drug
targets,
has
been
shown
to
play
an
important
role
in
viral
entry,
tissue
tropism,
pathogenesis.
In
this
review,
we
summarize
molecular
interaction
between
S
protein
host
factors,
especially
receptor-mediated
modulation
signaling
pathways,
highlight
progression
potential
therapeutic
prophylactic
agents
prevention
treatment
infection.
Frontiers in Materials,
Journal Year:
2023,
Volume and Issue:
9
Published: Jan. 11, 2023
In
December
2019,
Coronavirus
pandemic
(COVID-19)
caused
by
Severe
Acute
Respiratory
Syndrome
2
(SARS-CoV-2)
viruses,
which
affected
the
whole
world,
is
emerged.
The
details
on
epidemiology,
infection
source,
transmission
mode,
and
prognosis
of
SARS-CoV-2
gave
in
this
review.
Universal
control
standards
such
as
hand
hygiene,
environmental
cleanliness,
use
personal
protective
equipment,
quarantine
used
to
prevent
spread
COVID-19
without
vaccine.
However,
many
vaccine
candidate
studies
carried
out
globally
with
using
traditional
technological
approaches.
Innovations
technology
allow
development
nanotechnological
tools
formation
systems
that
will
inactivate
patients.
It
expected
include
technologies
combine
different
disciplines,
especially
robotic
applications,
antimicrobial
nanotechnology,
tissue
engineering
for
future
treatment
COVID-19.
This
review-based
work
discusses
relationship
nanotechnology
based
working
principles.
Viruses,
Journal Year:
2025,
Volume and Issue:
17(3), P. 378 - 378
Published: March 6, 2025
It
is
essential
to
comprehend
the
humoral
immune
response
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
and
its
vaccines
maximize
effectiveness
of
anti-SARSCoV-2
community
immunization
efforts.
The
aim
this
cross-sectional
study
was
determine
seroprevalence
anti-SARS-CoV-2
IgM/IgG
among
newcomer
students
at
Kafr
Elsheikh
University
in
Egypt,
whether
they
had
been
vaccinated
or
not.
Blood
samples
from
400
healthy
(200
non-vaccinated
200
vaccinated)
were
evaluated
for
presence
using
colloidal
gold
immunochromatography
lateral
flow
immunoassay
cards,
then
results
confirmed
by
specific
ELISA
tests.
prevalence
antibodies
participants
(n
=
400)
56.3%
IgG
13.3%
IgM.
Regarding
participants,
55.0%
females,
mean
age
18.2
years,
BMI
25.35.
58.5%
18.1
25.3.
There
statistically
non-significant
correlations
(p
˃
0.05)
between
gender,
BMI,
each
IgM-
IgG-positivity
both
groups.
In
total,
41.5%
48.5%
IgM-positive
IgG-positive
non-vaccinated,
respectively.
Furthermore,
51.5%
vaccinated,
No
significant
association
immunoglobulins
positivity
immunological
nonsmokers,
people
who
exercise
regularly,
those
take
vitamin
supplements,
eat
a
balanced
diet,
use
certain
herbs
noteworthy.
Among
subjects,
96.6%,
25.0%,
31.9%,
45.7%,
7.8%
group,
versus
97.2%,
60.6%,
64.2%,
52.3%,
6.4%
exercisers,
taking
eating
herbs,
93.5%,
32.3%,
35.5%,
48.4%,
6.5%
100.0%,
63.6%,
81.8%,
45.5%,
4.5%
physical
supplement
users,
eaters,
herbalists,
Persons
are
free
comorbidities,
young,
non-obese,
non-smokers,
engage
exercise,
vitamins,
immunostimulant
herbal
all
have
strong
response,
even
if
not
vaccinated.
During
pandemics,
vaccination
group
should
be
priority
preserve
vaccine
doses
high-risk
vulnerable
people.
Even
there
lockdown
during
an
anticipated
future
epidemic
pandemic,
we
prioritize
lifestyle
choices,
along
with
increasing
activity.
International Journal of Environmental Research and Public Health,
Journal Year:
2021,
Volume and Issue:
18(21), P. 11008 - 11008
Published: Oct. 20, 2021
The
hustle
and
bustle
of
the
planet
Earth
have
come
to
a
halt
thanks
novel
coronavirus.
virus
has
affected
approximately
219
million
people
globally;
taken
lives
4.55
patients
as
September
2021;
created
an
ambiance
fear,
social
distancing,
economic
instability.
purpose
this
review
article
is
trace
historical
origin
evolution
severe
acute
respiratory
syndrome
coronavirus
type
2
(SARS-CoV-2).
highly
contagious
with
unique
feature
rapid
mutations—the
scientific
research
paving
way
for
discoveries
regarding
disease
(COVID-19)
diagnosis,
features,
prevention,
vaccination.
connections
between
pandemic
dental
practices
are
essential
because
COVID-19
transmitted
by
aerosols,
fomites,
droplets,
which
also
produced
during
procedures,
putting
both
patient
dentist
at
risk.
main
emphasis
paper
highlight
psychological,
economic,
impact
on
throughout
world
under
what
circumstances
guidelines
can
health
care
be
provided.
In
current
situation
pandemic,
appropriate
screening
tool
must
established
either
using
molecular
testing
or
saliva
point-of-care
technology,
will
effective
in
identifying
well
isolating
potential
contacts
carriers
hopes
contain
mitigate
infection.
blessing
disguise
that
united
leaders,
scientists,
providers,
all
professions
from
around
fight
against
common
enemy.
Journal of Medical Virology,
Journal Year:
2022,
Volume and Issue:
94(9), P. 4071 - 4087
Published: April 30, 2022
Since
the
outbreak
of
coronavirus
disease
2019
(COVID-19)
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection,
global
public
health
and
economy
have
suffered
unprecedented
damage.
Based
on
increasing
related
literature,
characteristics
pathogenic
mechanisms
virus,
epidemiological
clinical
features
are
being
rapidly
discovered.
The
spike
glycoprotein
(S
protein),
as
a
key
antigen
SARS-CoV-2
for
developing
vaccines,
antibodies,
drug
targets,
has
been
shown
to
play
an
important
role
in
viral
entry,
tissue
tropism,
pathogenesis.
In
this
review,
we
summarize
molecular
interaction
between
S
protein
host
factors,
especially
receptor-mediated
modulation
signaling
pathways,
highlight
progression
potential
therapeutic
prophylactic
agents
prevention
treatment
infection.